Rehana Ahmed Saucedo
Dermatology · Burnsville, MNNPI 1427243898
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.4%), food and beverage and education — rather than concentrated in one kind of arrangement. Galderma Laboratories, L.p. accounts for 60.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $602 and has fallen 98.7% since, to $8 in 2024.
Across 19 payments — averaging $39.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$460
- AbbVie$108
- Biofrontera Inc.$56
- UCB, Inc.$50
- Regeneron Healthcare Solutions, Inc.$31
- Amgen$30
- plus $23 from 2 others
What the payments were for
- Speaking & faculty fees$45059%
- Food & beverage$27837%
- Education$304%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 2 | $460 |
| AbbVie(2 entities) | 6 | $108 |
| Biofrontera Inc. | 4 | $56 |
| UCB, Inc. | 1 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $31 |
| Amgen | 2 | $30 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Prugen, Inc. Pharmaceuticals | 1 | $5 |
How this compares
$758 in reported general payments places this provider in the 70th percentile of 273 dermatology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 37 | $2,475 |
| Clobetasol Propionate | 41 | $1,228 |
| Ketoconazole | 75 | $1,150 |
| Metronidazole | 20 | $1,110 |
| Gentamicin Sulfate | 31 | $909 |
| Fluocinonide | 19 | $542 |
| Doxycycline Monohydrate | 18 | $518 |
| Betamethasone Dipropionate | 12 | $489 |
| Triamcinolone Acetonide | 59 | $459 |
| Mupirocin | 74 | $457 |
| ValacyclovirValacyclovir Hcl | 19 | $332 |
| Cephalexin | 39 | $193 |
| Hydrocortisone | 20 | $68 |
| Amoxicillin | 12 | $57 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Burnsville
- Heidi FosterBurnsville$1K
- Kristina ShafferEagan$538K
- Margareth Pierre-LouisMinneapolis$439K
- Maria HordinskyMinneapolis$85K
- Afsaneh AlaviRochester$71K
- Todd SeelhammerSaint Paul$63K
- Brittney SchultzMinneapolis$52K
- David PearsonMinneapolis$46K
- Phillip EckerWayzata$31K
- Noah GoldfarbMinneapolis$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.